Dr. Balakrishnan, Dr. Senthil. v, Dr. A. S. Mokan Raj


Oral malignancy is one of the commonest cancer in Asian countries

and India. Combined abuse of alcohol and tobacco is not additive in terms of the odds ratio but multiplicative and the causative agent smoking, quid of chewing pan are important causes, tobacco, betel nut, alcohol, human papilloma virus. Most common malignancy of the oral cavity is squamous cell carcinoma and second most is minor salivary gland tumours. The histopathologic grade of tumour is related to its biological behaviour. The main purpose of this study is to correlate all clinical parameters like gender, age, site, habit with different grade of squamous cell carcinoma and predict the tumour biology. Its observational study. An analysis of the incidence, predisposing factors, premalignant conditions, clinical features, type of growth, histological types, stage of presentation and treatment modalities carried out for oral cancers in our hospital. With the invent of Radio sensitisers and Radio protectors, the radiotherapy as a modality of treatment has to be considered as side effects are low. Role of adjuvant chemo and concomitant role of chemo & radiotherapy are effective for advanced oral malignancy. Government organizations will create awareness and help in prevention. Younger population is to be educated by mass media with a ban on advertisement of Tobacco, Alcohol and screening camps will also be useful.



Full Text:



American Cancer Society. Cancer Facts & Figures 2016. Atlanta, Ga: American Cancer Society: 2016.

American Joint Committee on Cancer. Lip and Oral Cavity. In: AJCC Cancer Staging Manual, 7th ed. New York, Springer: 2010; 29–35

American Joint Committee on Cancer. Pharynx. In: AJCC Cancer Staging Manual, 7th ed. New York, Springer: 2010; 41–49.

Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.

Atkinson JC, Harvey KE, Domingo DL, et al. Oral and dental phenotype of dyskeratosis congenita. Oral Dis. 2008;14:419–427.

Brown LM, McCarron P, Freedman DM. New Malignancies Following Cancer of the Buccal Cavity and Pharynx. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr. (eds). New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute. NIH Publ. No. 05-5302. Bethesda, MD, 2006. Accessed on 4/18/2014 at / publications /mpmono/MPMonograph_complete.pdf.

Bsoui SA, Huber MA, Terezhalmy GT. Squamous cell carcinoma of the oral tissues: A comprehensive review for oral healthcare providers. J Contemp Dent Pract. 2005;4:1–16.

Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011 Nov 10;29(32):4294-4301. Epub 2011Oct 3.

Cogliano V, Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol. 2004;5:708.

D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–1956.

Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703. Epub 2012 Jan 26.

Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control. 2005;16:347–358.

Herrero R, Castellsagué X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772-1783.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD,, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Koch WM, Stafford E, Bajaj G. Cancer of the Oral Cavity. Part A: General Principles and Management. In: Harrison LB, Sessions RB, Hong WK, eds. Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia, Pa: Lippincott Williams and Wilkins; 2009: 250–265.

Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003;129:106–112.

Menedenhall WM, Werning JW, Pfister DG. Treatment of head and neck cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:729–780.

National Cancer Institute. Physician Data Query (PDQ). Lip and Oral Cavity Cancer Treatment. 2/28/2014. Accessed at HealthProfessional on June 5, 2014.

National Cancer Institute. Physician Data Query (PDQ). Oropharyngeal Cancer Treatment. 12/12/2013. Accessed at Professional on June 5, 2014.

National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers.V.2.2014. Accessed at on June 5, 2014.

Paleri V, Rees G, Arullendran P, et al. Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: A diagnostic meta-analysis. Head Neck. 2005;27:739–747.

Piccirillo JF, Costas I, Riechmann ME. Cancers of the Head and Neck. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD,Horner M-J (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program,

NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Quon H. Cancer of the head and neck. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa. Elsevier; 2008: 1177–1228.

Vartanian JG, Magrin J, Kowalski LP. Total glossectomy in the organ preservation era. Curr Opin Otolaryngol Head Neck Surg. 2010;18:95–100.

Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359:1116–1127.

Wrangle JM. Khuri FR. Chemoprevention of squamous cell carcinoma of the head and neck. Current Opinion in Oncology.2007;19:180–187.


  • There are currently no refbacks.